Control of renal medullary blood flow by vasopressin V1 and V2 receptors

K. Nakanishi, D. L. Mattson, V. Gross, R. J. Roman, A. W. Cowley

Research output: Contribution to journalArticle

Abstract

Experiments were performed in anesthetized renal-denervated rats to determine the contribution of renal medullary vasopressin V1 and V2 receptor stimulation in the regulation of renal medullary blood flow. Renal medullary interstitial infusion of the selective V1 agonist [Phe2,Ile3,Orn8]vasopressin (2 ng · kg-1 · min-1) significantly decreased outer medullary blood flow by 15% and inner medullary blood flow by 35%, as measured with implanted optical fibers for laser-Doppler flowmetry. Medullary interstitial infusion of equimolar doses of arginine vasopressin (AVP) also decreased outer medullary blood flow by 15% but decreased inner medullary blood flow by only 17%, a decrease significantly less than that during the infusion of the V1 agonist. These results were confirmed in videomicroscopy experiments on the exposed papilla, which demonstrated that the V1 agonist and AVP decreased descending and ascending vasa recta capillary red blood cell velocity and calculated blood flow, with greater decreases during infusion of the V1 agonist. In further laser-Doppler flowmetry studies, stimulation of V2 receptors by medullary interstitial infusion of 1-desamino-8-D-arginine vasopressin (2 ng · kg-1 · min-1) or AVP in rats pretreated with the vasopressin V1 receptor antagonist d(CH2)5[Tyr(Me)2,Ala-NH2]AVP increased renal medullary blood flow by 16 ± 3 and 27 ± 8%, respectively. The present experiments indicate that vasopressin V1 receptor stimulation serves to decrease renal medullary blood flow while V2 receptor stimulation appears to increase renal medullary blood flow; however, the net effect of AVP is to decrease renal medullary blood flow.

Original languageEnglish (US)
Pages (from-to)R193-R200
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume269
Issue number1 38-1/II
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Vasopressin Receptors
Renal Circulation
Arginine Vasopressin
Laser-Doppler Flowmetry
Kidney
Optical Fibers
Deamino Arginine Vasopressin
Video Microscopy
Blood Flow Velocity
Vasopressins
Rectum
Erythrocytes

Cite this

Nakanishi, K., Mattson, D. L., Gross, V., Roman, R. J., & Cowley, A. W. (1995). Control of renal medullary blood flow by vasopressin V1 and V2 receptors. American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 269(1 38-1/II), R193-R200.

Control of renal medullary blood flow by vasopressin V1 and V2 receptors. / Nakanishi, K.; Mattson, D. L.; Gross, V.; Roman, R. J.; Cowley, A. W.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 269, No. 1 38-1/II, 01.01.1995, p. R193-R200.

Research output: Contribution to journalArticle

Nakanishi, K. ; Mattson, D. L. ; Gross, V. ; Roman, R. J. ; Cowley, A. W. / Control of renal medullary blood flow by vasopressin V1 and V2 receptors. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 1995 ; Vol. 269, No. 1 38-1/II. pp. R193-R200.
@article{4532b67cce454b729b6235ed1d3c0f05,
title = "Control of renal medullary blood flow by vasopressin V1 and V2 receptors",
abstract = "Experiments were performed in anesthetized renal-denervated rats to determine the contribution of renal medullary vasopressin V1 and V2 receptor stimulation in the regulation of renal medullary blood flow. Renal medullary interstitial infusion of the selective V1 agonist [Phe2,Ile3,Orn8]vasopressin (2 ng · kg-1 · min-1) significantly decreased outer medullary blood flow by 15{\%} and inner medullary blood flow by 35{\%}, as measured with implanted optical fibers for laser-Doppler flowmetry. Medullary interstitial infusion of equimolar doses of arginine vasopressin (AVP) also decreased outer medullary blood flow by 15{\%} but decreased inner medullary blood flow by only 17{\%}, a decrease significantly less than that during the infusion of the V1 agonist. These results were confirmed in videomicroscopy experiments on the exposed papilla, which demonstrated that the V1 agonist and AVP decreased descending and ascending vasa recta capillary red blood cell velocity and calculated blood flow, with greater decreases during infusion of the V1 agonist. In further laser-Doppler flowmetry studies, stimulation of V2 receptors by medullary interstitial infusion of 1-desamino-8-D-arginine vasopressin (2 ng · kg-1 · min-1) or AVP in rats pretreated with the vasopressin V1 receptor antagonist d(CH2)5[Tyr(Me)2,Ala-NH2]AVP increased renal medullary blood flow by 16 ± 3 and 27 ± 8{\%}, respectively. The present experiments indicate that vasopressin V1 receptor stimulation serves to decrease renal medullary blood flow while V2 receptor stimulation appears to increase renal medullary blood flow; however, the net effect of AVP is to decrease renal medullary blood flow.",
keywords = "kidney medulla, laser-Doppler flowmetry, renal circulation",
author = "K. Nakanishi and Mattson, {D. L.} and V. Gross and Roman, {R. J.} and Cowley, {A. W.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "269",
pages = "R193--R200",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 38-1/II",

}

TY - JOUR

T1 - Control of renal medullary blood flow by vasopressin V1 and V2 receptors

AU - Nakanishi, K.

AU - Mattson, D. L.

AU - Gross, V.

AU - Roman, R. J.

AU - Cowley, A. W.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Experiments were performed in anesthetized renal-denervated rats to determine the contribution of renal medullary vasopressin V1 and V2 receptor stimulation in the regulation of renal medullary blood flow. Renal medullary interstitial infusion of the selective V1 agonist [Phe2,Ile3,Orn8]vasopressin (2 ng · kg-1 · min-1) significantly decreased outer medullary blood flow by 15% and inner medullary blood flow by 35%, as measured with implanted optical fibers for laser-Doppler flowmetry. Medullary interstitial infusion of equimolar doses of arginine vasopressin (AVP) also decreased outer medullary blood flow by 15% but decreased inner medullary blood flow by only 17%, a decrease significantly less than that during the infusion of the V1 agonist. These results were confirmed in videomicroscopy experiments on the exposed papilla, which demonstrated that the V1 agonist and AVP decreased descending and ascending vasa recta capillary red blood cell velocity and calculated blood flow, with greater decreases during infusion of the V1 agonist. In further laser-Doppler flowmetry studies, stimulation of V2 receptors by medullary interstitial infusion of 1-desamino-8-D-arginine vasopressin (2 ng · kg-1 · min-1) or AVP in rats pretreated with the vasopressin V1 receptor antagonist d(CH2)5[Tyr(Me)2,Ala-NH2]AVP increased renal medullary blood flow by 16 ± 3 and 27 ± 8%, respectively. The present experiments indicate that vasopressin V1 receptor stimulation serves to decrease renal medullary blood flow while V2 receptor stimulation appears to increase renal medullary blood flow; however, the net effect of AVP is to decrease renal medullary blood flow.

AB - Experiments were performed in anesthetized renal-denervated rats to determine the contribution of renal medullary vasopressin V1 and V2 receptor stimulation in the regulation of renal medullary blood flow. Renal medullary interstitial infusion of the selective V1 agonist [Phe2,Ile3,Orn8]vasopressin (2 ng · kg-1 · min-1) significantly decreased outer medullary blood flow by 15% and inner medullary blood flow by 35%, as measured with implanted optical fibers for laser-Doppler flowmetry. Medullary interstitial infusion of equimolar doses of arginine vasopressin (AVP) also decreased outer medullary blood flow by 15% but decreased inner medullary blood flow by only 17%, a decrease significantly less than that during the infusion of the V1 agonist. These results were confirmed in videomicroscopy experiments on the exposed papilla, which demonstrated that the V1 agonist and AVP decreased descending and ascending vasa recta capillary red blood cell velocity and calculated blood flow, with greater decreases during infusion of the V1 agonist. In further laser-Doppler flowmetry studies, stimulation of V2 receptors by medullary interstitial infusion of 1-desamino-8-D-arginine vasopressin (2 ng · kg-1 · min-1) or AVP in rats pretreated with the vasopressin V1 receptor antagonist d(CH2)5[Tyr(Me)2,Ala-NH2]AVP increased renal medullary blood flow by 16 ± 3 and 27 ± 8%, respectively. The present experiments indicate that vasopressin V1 receptor stimulation serves to decrease renal medullary blood flow while V2 receptor stimulation appears to increase renal medullary blood flow; however, the net effect of AVP is to decrease renal medullary blood flow.

KW - kidney medulla

KW - laser-Doppler flowmetry

KW - renal circulation

UR - http://www.scopus.com/inward/record.url?scp=0028891157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028891157&partnerID=8YFLogxK

M3 - Article

C2 - 7631893

AN - SCOPUS:0028891157

VL - 269

SP - R193-R200

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 38-1/II

ER -